Immune modulation strategies to reduce in-stent restenosis
Biomaterials Science · 2025 · 13 (18) · 4898-4915
DOI: 10.1039/d5bm00687b ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Biomaterials Science, 2025. Verfasst von Mei Yu und 3 weiteren Autor:innen. Beteiligte Einrichtung: The Xiaoshan Hospital Affiliated to Wenzhou Medical University, Hangzhou, 310201, China. Hauptthemen laut MEDLINE: Stents, Coronary Restenosis, Immunomodulation. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 233 Literaturangaben. Gefördert von: Natural Science Foundation of Zhejiang Province.
Abstract (Originalsprache)
In-stent restenosis (ISR) remains a significant complication following stent implantation, driven by complex interactions between immune responses, vascular injury, and inflammatory cascades.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- The Xiaoshan Hospital Affiliated to Wenzhou Medical University, Hangzhou, 310201, China.
- The First School of Clinical Medicine of Zhejiang Chinese Medical University, Hangzhou, 310003, China.
- Department of Cardiology, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, 310016, China. jyfu@zju.edu.cn.
Förderung
- Natural Science Foundation of Zhejiang Province
Zitieren
APA
Yu, M., Dai, C., Shi, J., & Fu, J. (2025). Immune modulation strategies to reduce in-stent restenosis. Biomaterials Science, 13(18), 4898-4915. https://doi.org/10.1039/d5bm00687b
Vancouver
Yu M, Dai C, Shi J, Fu J. Immune modulation strategies to reduce in-stent restenosis. Biomaterials Science. 2025;13(18):4898-4915. doi:10.1039/d5bm00687b
BibTeX
@article{Yu2025,
author = {Yu, Mei and Dai, Chengyi and Shi, Jingjing and Fu, Jiayin},
title = {Immune modulation strategies to reduce in-stent restenosis},
journal = {Biomaterials Science},
year = {2025},
volume = {13},
number = {18},
pages = {4898--4915},
doi = {10.1039/d5bm00687b}
}
EUVIMED